Ardent Health Partners, LLC (NYSE:ARDT) Shares Purchased by State of Wyoming

State of Wyoming lifted its position in Ardent Health Partners, LLC (NYSE:ARDT) by 123.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 31,693 shares of the company’s stock after purchasing an additional 17,499 shares during the quarter. State of Wyoming’s holdings in Ardent Health Partners were worth $541,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of ARDT. Point72 Asia Singapore Pte. Ltd. purchased a new position in shares of Ardent Health Partners during the 4th quarter worth $27,000. US Bancorp DE purchased a new position in Ardent Health Partners during the fourth quarter worth about $31,000. R Squared Ltd acquired a new stake in shares of Ardent Health Partners during the fourth quarter valued at about $37,000. New York State Common Retirement Fund acquired a new stake in shares of Ardent Health Partners during the fourth quarter valued at about $48,000. Finally, Deutsche Bank AG lifted its holdings in shares of Ardent Health Partners by 1,251.9% in the 4th quarter. Deutsche Bank AG now owns 2,866 shares of the company’s stock worth $49,000 after acquiring an additional 2,654 shares during the last quarter.

Ardent Health Partners Price Performance

ARDT stock opened at $15.09 on Tuesday. The business’s 50-day moving average is $13.16 and its two-hundred day moving average is $14.79. The company has a debt-to-equity ratio of 0.78, a current ratio of 1.91 and a quick ratio of 1.78. The firm has a market capitalization of $2.16 billion and a P/E ratio of 9.26. Ardent Health Partners, LLC has a 1 year low of $11.31 and a 1 year high of $20.72.

Ardent Health Partners (NYSE:ARDT) last released its earnings results on Tuesday, May 6th. The company reported $0.29 earnings per share for the quarter, topping analysts’ consensus estimates of $0.21 by $0.08. The firm had revenue of $1.50 billion for the quarter, compared to analysts’ expectations of $1.50 billion. Analysts anticipate that Ardent Health Partners, LLC will post 1.23 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

ARDT has been the subject of a number of research analyst reports. Royal Bank of Canada reiterated an “outperform” rating and issued a $21.00 target price on shares of Ardent Health Partners in a report on Thursday, May 15th. Stephens reaffirmed an “overweight” rating and issued a $22.00 price objective on shares of Ardent Health Partners in a research note on Tuesday, April 1st. Morgan Stanley cut their price objective on Ardent Health Partners from $23.50 to $22.00 and set an “overweight” rating on the stock in a report on Tuesday, January 21st. Guggenheim raised their target price on Ardent Health Partners from $16.00 to $18.00 and gave the company a “buy” rating in a report on Friday, May 9th. Finally, Mizuho cut their price target on shares of Ardent Health Partners from $19.00 to $18.00 and set an “outperform” rating on the stock in a research note on Wednesday, April 9th. Two research analysts have rated the stock with a hold rating, nine have given a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat.com, Ardent Health Partners presently has a consensus rating of “Buy” and an average price target of $20.75.

Ardent Health Partners Company Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.